Allopurinol Tablet shortage
To Be Discontinued 4 presentations · 1 manufacturers · first FDA posting 2026-02-19 · last update 2026-02-19
Manufacturers: Teva Pharmaceuticals USA, Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Allopurinol, Tablet, 100 mg (NDC 0591-5543-01) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 02/19/2026 Updated 02/19/2026 Discontinued 02/19/2026 |
| Allopurinol, Tablet, 100 mg (NDC 0591-5543-10) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 02/19/2026 Updated 02/19/2026 Discontinued 02/19/2026 |
| Allopurinol, Tablet, 300 mg (NDC 0591-5544-01) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 02/19/2026 Updated 02/19/2026 Discontinued 02/19/2026 |
| Allopurinol, Tablet, 300 mg (NDC 0591-5544-05) | Teva Pharmaceuticals USA, Inc. | To Be Discontinued | — | Discontinuation of the manufacture of the drug | Posted 02/19/2026 Updated 02/19/2026 Discontinued 02/19/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)